Genetic deletion of histone deacetylase 6 prevents peritoneal fibrosis via suppression of heat shock protein 90 deacetylation
The Journal of Pathology · 2025
DOI: 10.1002/path.6436 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2025. Verfasst von Yingfeng Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, PR China. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Peritoneal Fibrosis, HSP90 Heat-Shock Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Scientific Committee of China, Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
Peritoneal fibrosis (PF) is a serious complication contributing to ultrafiltration failure in patients undergoing peritoneal dialysis that currently lacks effective treatment strategies. Our recent studies highlighted the key role of histone deacetylase 6 (HDAC6) in the development of PF. To better understand the mechanisms underlying the involvement of HDAC6 in PF, we conducted in vivo experiments using Hdac6 KO mice and in vitro studies using human peritoneal mesothelial cells (HPMCs). Our results demonstrated that HDAC6 gene silencing improved PF and angiogenesis in vivo and altered pathological phenotypes in vitro . In Hdac6 KO mice, the key pathways regulating extracellular matrix accumulation, angiogenesis, and secretion of inflammatory cytokines (including TGFB1/SMAD3, HIF‐1α/VEGFR‐2/MAPK3/MAPK1, and TLR4/NF‐κB pathways) were inhibited. We also identified heat shock protein 90 (HSP90) as the substrate of HDAC6 in both PF mice and HPMCs and demonstrated that HDAC6 exerted its regulatory function in PF through the deacetylation of HSP90. Overall, our study provides novel insights into the critical role of the HDAC6‐HSP90 interplay in PF using Hdac6 KO mice. We identify HSP90 as an essential substrate through which HDAC6 exerts its function in PF, providing an experimental basis for the development of novel therapeutic strategies. © 2025 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, PR China.
- Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Na Liu
Förderung
- National Natural Science Foundation of China
- Shanghai Scientific Committee of China
- Shanghai Pudong New Area Health Commission
- Shanghai Sailing Program
- Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai
- Shanghai Health Bureau and Shanghai administration of Traditional Chinese Medicine (TCM), PR China
- Pudong Health Bureau of Shanghai
- Shanghai Pudong New Area
Zitieren
APA
Shi, Y., Li, J., Zhong, Q., Chen, H., Ma, X., Hu, Y., Wang, Y., Jiang, D., Zhou, X., Li, X., Zhuang, S., & Liu, N. (2025). Genetic deletion of histone deacetylase 6 prevents peritoneal fibrosis via suppression of heat shock protein 90 deacetylation. The Journal of Pathology. https://doi.org/10.1002/path.6436
Vancouver
Shi Y, Li J, Zhong Q, Chen H, Ma X, Hu Y, et al. Genetic deletion of histone deacetylase 6 prevents peritoneal fibrosis via suppression of heat shock protein 90 deacetylation. The Journal of Pathology. 2025. doi:10.1002/path.6436
BibTeX
@article{Shi2025,
author = {Shi, Yingfeng and Li, Jinqing and Zhong, Qin and Chen, Hui and Ma, Xiaoyan and Hu, Yan and Wang, Yishu and Jiang, Daofang and Zhou, Xun and Li, Xialin and Zhuang, Shougang and Liu, Na},
title = {Genetic deletion of histone deacetylase 6 prevents peritoneal fibrosis via suppression of heat shock protein 90 deacetylation},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6436}
}
EUVIMED